CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Gujarat Themis Biosyn Limited Company Snapshot
Gujarat Themis Biosyn Limited operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Gujarat Themis Biosyn Limited with three other pharmaceutical manufacturers in Asia: Source Natural Foods and Herbal Supplements Ltd (2018 sales of 108.39 million Indian Rupees [US$1.59 million] ), Natural Capsules Limited (547.55 million Indian Rupees [US$8.01 million] ), and Reprocell Inc which is based in Japan (926.26 million Japanese Yen [US$8.41 million] ).

Sales Analysis. Gujarat Themis Biosyn Limited reported sales of 388.00 million Indian Rupees (US$5.68 million) for the fiscal year ending March of 2018. This represents an increase of 8.7% versus 2017, when the company's sales were 356.92 million Indian Rupees. Sales at Gujarat Themis Biosyn Limited have increased during each of the previous five years (and since 2013, sales have increased a total of 37%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Gujarat Themis Biosyn Limited
  Stock Performance Chart for Gujarat Themis Biosyn Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (5/25/2018): 36.75
(Figures in Indian Rupees)
1 Week 0.7%   13 Weeks -12.7%  
4 Weeks -20.7%   52 Weeks -18.2%  
 
Gujarat Themis Biosyn Limited Key Data:
  Ticker: 506879 Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 387,999,000
(Year Ending Jan 2019).
Employees: N/A
  Currency: Indian Rupees Market Cap: 533,904,000
  Fiscal Yr Ends: March Shares Outstanding: 14,528,000
  Share Type: Ordinary Closely Held Shares: 11,025,350
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.